Northwestern scientists have developed a new nanostructure that supercharges CRISPR’s ability to safely and efficiently enter cells, potentially unlocking its full power to treat genetic diseases. By ...

Multisystemic smooth muscle dysfunction syndrome (MSMDS) is a rare condition associated with stroke, aortic dissection ...

A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...

Researchers have unveiled a new type of nanostructure that dramatically improves CRISPR delivery. Called lipid nanoparticle ...

Researchers engineered a bespoke CRISPR-Cas9 gene-editing enzyme to develop a potential therapy for MSMDS, which ...

Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.

Oral presentation highlights significant reduction in HBV DNA integration and other clinically-relevant biomarkers from the EBT-107 therapeutic ...

The global CRISPR-based gene editing market size is projected to grow from USD 4.46 billion in 2025 to over USD 13.39 billion by 2034, expanding at a CAGR of 13%. Growth is fueled by advancements in ...

Global genome editing market to reach $37.22 Billion by 2033, fueled by genetic therapy pipelines, CRISPR, and biotech funding. Investments in biotech and precision therapies are accelerating the ...

Medical anthropologist and bioethicist Julia Brown says scientists and nonscientists need to talk about whether and how we should use CRISPR to edit the fetal genome. When you purchase through links ...